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Background: Edge restenosis is considered to be associated with residual plaque. We assessed the baseline plaque characteristics at the site of 
edge restenosis after stent implantation using integrated backscatter IVUS (IB-IVUS).
Methods: We included 22 lesions with either edge restenosis at mid-term follow-ups among 394 de novo lesions treated with bare metal stent 
(BMS) or drug-eluting stent (DES). Post-procedure IVUS analysis was performed in both proximal and distal 5mm reference using a dedicated 
software. External elastic membrane cross-sectional area (CSA), lumen CSA, plaque plus media CSA were measured with gray-scale IVUS. Using IB-
IVUS, plaque characteristics were further classified as fibrosis, calcification and lipid. Restenosis site vs. non restenosis site was compared using 
paired t-test. 
Results: Complete IVUS pullback images were acquired in 16/22 lesions. Follow-up timing was 206±68 days. Sixty-nine % of patients were male, 
88% had stable angina, 31% had diabetes, 51% had hyperlipidemia, 56% had hypertension. DES was implanted in 63% of lesions, and LAD was 
the target vessel in 81% of lesions. Seventy-five % of edge restenosis occurred in the proximal reference. Incidence of edge dissection at either 
restenosis or non restenosis site, and both were 13%, 6%, and 19% respectively. IVUS results are shown in Table.
Conclusions: IB-IVUS suggested larger plaque volume with higher % lipid content in the reference associated with future edge restenosis, when 
treated with either BMS or DES. 
Restenosis site Non Restenosis site p
Mean external elastic membrane CSA, cm2 12.0±4.3 9.34±3.82 0.05
Mean lumen CSA, cm2 6.08±2.03 6.70±2.12 0.31
Mean plaque plus media CSA, cm2 5.88±2.89 2.65±2.03 0.002
Plaque volume, cm3 29.40±14.46 13.24±10.14 0.002
Plaque ratio (P+M CSA / EEM-CSA ) 0.46±0.16 0.24±0.13 0.001
Fibrosis, % 54.4±12.7 65.5±16.9 0.038
Calcification, % 1.5±2.1 1.5±1.9 0.97
Lipid, % 39.5±12.9 28.9±13.4 0.025
